A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis
Clinical trial NCT04934072 · COMPLETED
Trial details
- NCT number
- NCT04934072
- Sponsor
- Fresenius Kabi SwissBioSim GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2023-08-07
- Enrollment
- 553
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.